Abboxia AB is a Swedish AB based in Mölndal, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2013, the company has 7 employees and reported revenue of SEK 58.8m in its latest annual filing.
Föremålet för bolagets verksamhet är att bedriva försäljning av läkemedel, läkemedelsnära produkter och annan därmed förenlig verksamhet. Vidare ska bolaget bedriva konsultverksamhet inom ovan nämnda områden, bedriva handel med värdepapper samt därmed förenlig verksamhet. Bolaget ska dessutom förvalta fast egendom samt därmed förenlig verksamhet.
In its most recent annual report (2025), Abboxia AB reported revenue of SEK 58.8m, an increase of 22% on the year before. The figures on this page draw on 5 annual filings covering 2022 to 2025. The bottom line showed a net profit of SEK 210.5k, and the EBITDA margin stood at 7.3%.
At the end of 2025, equity financed 43.9% of the balance sheet, and current assets covered short-term debt 2.3 times.
Frequently asked questions
What is the Org number of Abboxia AB?
Abboxia AB is registered with Bolagsverket / SCB under Org 5569249187.
What is the revenue of Abboxia AB?
Abboxia AB reported revenue of SEK 58.8m in 2025.
How many employees does Abboxia AB have?
Abboxia AB employs 7 people as of the latest annual report.
Who is the CEO of Abboxia AB?
Carl Fredrik Oskar S Andersch is the CEO of Abboxia AB, in role since 2026.
Where is Abboxia AB headquartered?
Abboxia AB's registered address is Johannefredsgatan 4.
